Omicron BQ variants resistant to antibody treatments are quickly becoming dominant in U.S.

By November 18, 2022Health

Omicron subvariants BQ.1 and BQ.1.1 now make up 44% of new Covid cases, compared with 32% last week, according to CDC data.

Spread the love
See also  Pfizer says omicron booster is better against new subvariants like BQ.1.1 than old shots

Leave a Reply